tiprankstipranks
Life Healthcare Group Holdings Limited (LTGHF)
OTHER OTC:LTGHF
US Market

Life Healthcare Group Holdings (LTGHF) Earnings Dates, Call Summary & Reports

5 Followers

Earnings Data

Report Date
May 21, 2026
TBA (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
Last Year’s EPS
-0.09
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Nov 27, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented a broadly positive operational and financial picture: solid revenue growth, strong cash generation, improved occupancy (above 70% in H2), attractive returns to shareholders, and clear growth projects underway. However, material challenges remain — notably the underperformance and integration issues in the Fresenius renal business, a small number of underperforming hospitals requiring asset optimization, accounting complexity and a sizeable Piramal liability from the LMI disposal, and near-term impairment and cost pressure. Management has articulated concrete remediation plans (asset optimization, cost savings of ZAR 400m, operational fixes) and targets to restore margins.
Company Guidance
Guidance for 2026 centres on growth, driving and optimisation with specific targets: management expects group occupancies of ~70%, PPD growth of ~1% and revenue growth of ~5%, plans to recruit ~140 specialists, deliver a 140‑bed greenfield (Life Paarl Valley) plus a further 89 acute beds (brownfield), add another cathlab and a vascular lab, deliver 40 acute rehabilitation beds, 20 renal stations and 3 PET‑CT sites, and bring cyclotrons into commercial production (Q2); it will acquire one remaining major property for ~ZAR 475m to own almost 100% of the portfolio, and pursue ZAR 400m of real cost savings over three years (20–25% of the saving targeted in year one), aim to restore Renal Dialysis margins to ~15–18% and complete all asset‑optimization decisions by year‑end 2026.
Revenue Growth
Group continuing operations revenue up 6% year-on-year; revenue per PPD grew 5.8% driven by a tariff increase of 5.1% and positive case mix.
Normalized Earnings and Profitability
Normalized earnings per share from continuing operations ~10% (normalized EPS reported at 10.1% pro forma); normalized EBITDA on continuing operations +4.7%.
Strong Cash Generation and Returns to Shareholders
Operating cash generation close to ZAR 4.6bn (up 23.8%); cash generation was 119.6% of EBITDA. Total shareholder distributions over the last 2 years ~ZAR 13bn; final dividend up 12% (ZAR 0.56) and total dividends for the year up ~12%.
Occupancy and Activity Recovery
Year average occupancy 69.7% with second-half occupancy slightly over 70%; PPD (patient day) growth ~1.1% for the year and top-performing cohorts showing stronger activity (top 20: PPD growth 1.3%; top 30: PPD growth 1.5%).
Strong Performance in Top Hospitals
Top 20 hospitals: occupancy 72%, revenue growth 7.4% and EBITDA growth 10.3%. Top 30 hospitals: occupancy 71%, revenue growth 7.2% and EBITDA growth 9.6%; top 30 account for ~96% of acute EBITDA.
Complementary Services Expansion
Complementary services revenue grew ~25% (including acquisitions); imaging and nuclear volumes increasing with 3 PET‑CTs expected in 2026 and cyclotrons awaiting regulatory sign-off; renal dialysis activity growth nearly 10% and Life Renal care moved to positive EBITDA in H2.
Balance Sheet Strength and Credit Rating
Net debt-to-EBITDA reported at 0.77 (including IFRS lease liabilities); credit rating improved to zaAAA. If Piramal liability treated as debt-like, net debt/EBITDA ~0.8 and management is comfortable with this leverage.
Growth and Capacity Additions
Greenfield 140-bed Life Paarl Valley project underway; brownfield additions: ~30 ICU/high-care beds and 39 general ward beds delivered during the year; plans to add a further 89 acute beds, 40 acute rehab beds, 20 renal stations and more imaging/cardiac labs in the coming year.

Life Healthcare Group Holdings (LTGHF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

LTGHF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 21, 2026
2026 (Q2)
- / -
-0.085
Nov 27, 2025
2025 (Q4)
- / 0.24
0.05374.00% (+0.19)
May 22, 2025
2025 (Q2)
- / -0.09
0.129-165.89% (-0.21)
Nov 26, 2024
2024 (Q4)
- / 0.05
-0.01600.00% (+0.06)
May 22, 2024
2024 (Q2)
- / 0.13
0.021514.29% (+0.11)
Nov 16, 2023
2023 (Q4)
- / -0.01
0.04-125.00% (-0.05)
May 25, 2023
2023 (Q2)
- / 0.02
0.027-22.22% (>-0.01)
Nov 17, 2022
2022 (Q4)
- / 0.04
0.045-11.11% (>-0.01)
May 26, 2022
2022 (Q2)
- / 0.03
0.034-20.59% (>-0.01)
Nov 18, 2021
2021 (Q4)
- / 0.04
-0.034232.35% (+0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

LTGHF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 22, 2025
$0.64$0.63-1.56%
Nov 26, 2024
$0.70$0.72+2.86%
May 22, 2024
$0.43$0.45+4.65%
Nov 16, 2023
$0.49$0.47-4.08%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Life Healthcare Group Holdings Limited (LTGHF) report earnings?
Life Healthcare Group Holdings Limited (LTGHF) is schdueled to report earning on May 21, 2026, TBA (Confirmed).
    What is Life Healthcare Group Holdings Limited (LTGHF) earnings time?
    Life Healthcare Group Holdings Limited (LTGHF) earnings time is at May 21, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is LTGHF EPS forecast?
          Currently, no data Available